Cancer Care Ontario (2012) Follow-up care, surveillance protocols and secondary prevention measures for survivors of colorectal cancer. [assessed in 2014 and endorsed in 2016]. https://cancercare.on.ca/common/pages/UserFile.aspx?fileId=124839 Belgian Healthcare Knowledge Centre (KCE) (2014) Colo...
Patients who were overdue for screening were selected based on Ontario's guidelines: women aged 21 and older who had not received a Pap test in three years were overdue forcervical cancer screening, women who had not received a mammogram in the last two years and were older than 50 were ov...
Ontario Institute for Cancer Research (OICR) is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cancer. The Institute is an independent, not-for-profit corporation, supported by the Government of Ontario. OICR supports more th...
Similar trends were observed for tumor stage and mode of detection (mammogram vs lump). Among all participants, those lacking both screening and regular care had larger tumors (21% vs 8%, RR = 2.51, 1.76–3.56) and advanced (3B +) stage (19% vs 6%, RR = 3.15, 2.15–...
Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J Natl Cancer Inst. 2011;103(12):942-950. doi:10.1093/jnci/djr138PubMedGoogle ScholarCrossref 28. Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor ...
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Prev Med. 2021;151:106586. doi:10.1016/j.ypmed.2021.106586 PubMedGoogle ScholarCrossref 15. Lang M, Yeung T,...
All individuals presenting for a scheduled mammogram at one of three clinics associated with a private health care system in Madison, WI were invited to participate during the period of October 6 through December 15, 2006. The study was approved by the University of Wisconsin-Madison Health ...
(high priority intervention), tier 2 (intermediate priority) and tier 3 (low priority)—informed by the Ontario Health Cancer Care Ontario framework of resource-prioritisation and by the ESMO Magnitude of Clinical Benefit Scale (MCBS), a public health tool intended to support the uptake of ...
The overall cohort included Ontario women aged 40–49 between April 1, 2009 and March 31, 2019. Subgroups were created: the "screen" group included women who received a mammogram defined as screening (using a set of exclusion criteria) and the "routine screen" group included women with three...
Toronto, Ontario: Hans Harbor; 1988:3-15 15. Shapiro S, Venet W, Strax P, Venet L. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986. Baltimore, Md: Johns Hopkins University Press; 1988 16. Nystrom L, Andersson I, Bjurstam N, Frisell ...